BioReliance has significant experience in assay development with both ELISA and MSD Electrochemiluminescence platforms and we currently offer a wide range of routine and custom immunoassays in support of preclinical and clinical testing as well as routine lot release and stability programs.
Enzyme Linked Immuno Sorbent Assay (ELISA) is a commonly used test that utilizes antibodies to detect and quantify specific analytes such as peptides, proteins, and hormones. The ELISA platform offers a sensitive and specific detection method that is also rapid and cost effective. At BioReliance, our scientists are experts at developing, validating, and optimizing ELISA tests for applications such as:
In addition to traditional ELISA methods, BioReliance also provides Electrochemiluminescence (ECL) detection through the Meso Scale Discovery (MSD) platform. ECL technology uses luminescence produced during electrochemical reactions to detect various types of analytes using specific antibody combinations. Compared to ELISA, ECL offers higher sensitivity, a wider dynamic range, and a reduced impact of matrix effects. The MSD multiplex platform and high throughput analysis allow for fast, low cost analysis with reduced sample volumes. The MSD platform provides flexibility in assay development, allowing for a broader assay menu that includes:
Whatever your assay requirements may be, BioReliance has the expertise and the technology to conduct full method development, optimization, validation, and high throughput sample analyses to ensure the quality of your therapeutic. Contact us today.
Apps, Tools, Newsletters & More...
Find the latest scientific resources from Sigma-Aldrich.
Copyright © 2017 Sigma-Aldrich Co. LLC. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Terms | Privacy | Site Map